Ads
related to: cervical cancer, approved- Advanced Cervical Cancer
Read About a Treatment Option
And The Benefits And Risks
- Clinical Study Trials
Clinical Study Results Information
Learn More Here Today
- Hear From a Patient
See How Patients Get The Chance
To Tell Their Story
- Access & Reimbursement
Financial Assistance May
Be Available. Learn More.
- Advanced Cervical Cancer
Search results
HPV vaccine provides real benefits for men, analysis shows
Colorado Springs Gazette· 7 days agoThe study of more than 3.4 million people is one of the first long-term analyses of the vaccine's...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoPfizer bought Tivdak in its acquisition of Seagen. Antibody drug conjugates, or ADCs, send toxic...
HPV vaccine provides real benefits for men, analysis shows
KSL Salt Lake City· 5 days agoVaccination of boys and men against the human papillomavirus reduces their risk of head and neck ...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 6 days agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific antibody, REGN7075 ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 4 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 6 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoIovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer ...
Dividend Deals: 3 Overlooked Stocks Offering Incredible Value
InvestorPlace· 3 days agoThere is no joy like receiving passive income each quarter. If you seek steady dividend income and long-term growth, consider the overlooked dividend stocks mentioned here. Whether you are only ...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks· 7 days agoFree Report) announced positive new results from an ongoing phase I/II study on pipeline candidate REGN7075. The phase I/II first-in-human, open-label study is evaluating REGN7075, in combination ...